Functional Resilience and Renal Recovery Post-Trauma under Pentaconjugate Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A 6-Month Follow-Up.

This addendum presents a 6-month clinical follow-up detailing the functional resilience and post-traumatic renal recovery achieved through pentaconjugate therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD). The report validates the clinical protocol developed by Consultora Kouro SpA (comprising metformin, divalproex sodium, cinacalcet, telmisartan, and amlodipine) in its capacity to synergistically inhibit cystogenesis and preserve nephro-functional reserve following acute high-energy trauma.